bioMérieux S.A. (BMXXY)
OTCMKTS · Delayed Price · Currency is USD
14.62
+0.79 (5.71%)
At close: Aug 5, 2025
bioMérieux Market Cap
bioMérieux has a market cap or net worth of $17.62 billion as of August 22, 2025. Its market cap has increased by 38.85% in one year.
Market Cap
17.62B
Enterprise Value
17.68B
Revenue
4.12B
Ranking
n/a
PE Ratio
39.38
Stock Price
$14.62
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.46B to 17.62B, an increase of 1,103.58%. That is a compound annual growth rate of 12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 17.62B | 39.35% |
| Dec 31, 2024 | 12.64B | -3.73% |
| Dec 29, 2023 | 13.14B | 6.03% |
| Dec 30, 2022 | 12.39B | -26.30% |
| Dec 31, 2021 | 16.81B | 0.64% |
| Dec 31, 2020 | 16.70B | 58.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |